| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |